MedPath

Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma

Conditions
Oral Cancer
Registration Number
NCT03877159
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust
Brief Summary

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. Caspase-8 is a key enzyme involved in controlling cell death. This study examines the importance of caspase-8 in oral cancer.

Detailed Description

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. The caspase family of enzymes are the key performers of controlled cell death and caspase-8 is frequently mutated in oral cancer. This study will perform DNA sequencing to determine if the gene is wild-type (not mutated). The abundance of inactive (uncleaved) and active (cleaved) caspase-8 will be determined. The levels of the proteins that caspase-8 interacts with (including caspase-3) will be determined. Results will be correlated with tumour stage, patient outcome and the presence of immune cells and other microscopic features. This will improve the understanding of the importance of caspase-8 in oral cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Oral cancer
  • Sufficient follow up data
Exclusion Criteria
  • Patient has indicated that they do not wish their tissue to be used for research.
  • . The quantity or quality of tissue is too little or poor to provide adequate material without significant reserve.
  • The material contains bone.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Caspase-8 activity in oral cancer and its impact on disease progressionUp to 3 years

Molecular analysis of caspase-8 activity will be undertaken and correlated with tumour features and outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Robert Kennedy

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath